These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10233433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [Abstract] [Full Text] [Related]

  • 3. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, van Vliet HH.
    Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
    [Abstract] [Full Text] [Related]

  • 4. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
    Hong S, Lee J, Chi H, Lee C, Nah S, Kim Y, Oh J, Moon H, Yoo B.
    Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acquired von Willebrand syndrome: features and management.
    Mohri H.
    Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821
    [Abstract] [Full Text] [Related]

  • 9. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C, Hilbert L, Vanhoorelbeke K, Deckmyn H, Goudemand J, Mazurier C.
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [Abstract] [Full Text] [Related]

  • 10. [IgA RIPA inhibitor in a case of acquired von Willebrand syndrome].
    Takai Y, Koya H, Himei S, Hayashi H.
    Rinsho Ketsueki; 1989 Dec; 30(12):2183-8. PubMed ID: 2621801
    [Abstract] [Full Text] [Related]

  • 11. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies.
    Jackson N, Hashim ZA, Zainal NA, Jamaluddin N.
    Singapore Med J; 1995 Apr; 36(2):230-1. PubMed ID: 7676276
    [Abstract] [Full Text] [Related]

  • 14. [Acquired von Willebrand syndrome associated with late onset systemic lupus erythematosus--a case report].
    Itoh T, Nakai M, Kitajima N, Kodama K, Takenaka M, Kishihara M, Inatome T, Inoh T, Oomae Y, Shimizu S.
    Rinsho Ketsueki; 1988 Feb; 29(2):195-202. PubMed ID: 3290540
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.
    van Genderen PJ, Boertjes RC, van Mourik JA.
    Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633
    [Abstract] [Full Text] [Related]

  • 16. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [Abstract] [Full Text] [Related]

  • 17. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
    Eikenboom JC, Tjernberg P, Van Marion V, Heering KJ.
    Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
    [Abstract] [Full Text] [Related]

  • 18. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
    Guermazi S, Conard J, Samama MM, Dellagi K.
    Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
    [Abstract] [Full Text] [Related]

  • 19. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Kasatkar P, Ghosh K, Shetty S.
    Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
    [No Abstract] [Full Text] [Related]

  • 20. Acquired type 2A von Willebrand disease in chronic myelocytic leukemia.
    Mohri H, Tanabe J, Yamazaki E, Yoshida M, Harano H, Matsuzaki M, Motomura S, Okubo T.
    Hematopathol Mol Hematol; 1996 Jan; 10(3):123-33. PubMed ID: 8878731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.